363 related articles for article (PubMed ID: 23580159)
1. Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome.
Baizabal-Carvallo JF; Bonnet C; Jankovic J
J Neural Transm (Vienna); 2013 Nov; 120(11):1579-89. PubMed ID: 23580159
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid syndrome damage index (DIAPS): distinct long-term kinetic in primary antiphospholipid syndrome and antiphospholipid syndrome related to systemic lupus erythematosus.
Torricelli AK; Ugolini-Lopes MR; Bonfá E; Andrade D
Lupus; 2020 Mar; 29(3):256-262. PubMed ID: 31986962
[TBL] [Abstract][Full Text] [Related]
4. Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome.
Yelnik CM; Kozora E; Appenzeller S
Curr Rheumatol Rep; 2016 Feb; 18(2):11. PubMed ID: 26923254
[TBL] [Abstract][Full Text] [Related]
5. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
6. Chorea as an initial and solitary manifestation of systemic lupus erythematosus with antiphospholipid syndrome in an elderly man.
Javed F; Piranavan P
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38290987
[TBL] [Abstract][Full Text] [Related]
7. Antibodies and clinical features of the antiphospholipid syndrome as criteria for systemic lupus erythematosus.
Merrill JT
Lupus; 2004; 13(11):869-76. PubMed ID: 15580985
[TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid syndrome and other lupus-related movement disorders.
Plowman EK; Okun MS
Handb Clin Neurol; 2011; 100():237-45. PubMed ID: 21496583
[No Abstract] [Full Text] [Related]
9. Aortitis is an under-recognized manifestation of antiphospholipid syndrome: A case report and literature review.
Escoda T; George J; Jarrot PA; Jean R; Mazodier K; Sanderson F; Poullin P; Saby L; Jourde-Chiche N; Kaplanski G; Chiche L
Lupus; 2022 May; 31(6):744-753. PubMed ID: 35341372
[TBL] [Abstract][Full Text] [Related]
10. [Systemic lupus erythematosus and antiphospholipid syndrome - diagnostic and therapeutic problems].
Zdrojewski Z
Wiad Lek; 2018; 71(1 pt 1):40-46. PubMed ID: 29558350
[TBL] [Abstract][Full Text] [Related]
11. Stroke in systemic lupus erythematosus and antiphospholipid syndrome: risk factors, clinical manifestations, neuroimaging, and treatment.
de Amorim LC; Maia FM; Rodrigues CE
Lupus; 2017 Apr; 26(5):529-536. PubMed ID: 28394226
[TBL] [Abstract][Full Text] [Related]
12. Cognitive disorders and antiphospholipid antibodies.
Yelnik CM; Kozora E; Appenzeller S
Autoimmun Rev; 2016 Dec; 15(12):1193-1198. PubMed ID: 27639839
[TBL] [Abstract][Full Text] [Related]
13. Coagulopathy as a complication of kidney biopsies in paediatric systemic lupus erythematosus patients with antiphospholipid syndrome.
Nagata H; Sato M; Ogura M; Yoshikawa T; Yamamoto K; Matsumura S; Kano Y; Saida K; Sako M; Kamei K; Yoshioka T; Ogata K; Ito S; Ishikura K
Nephrology (Carlton); 2018 Jun; 23(6):592-596. PubMed ID: 28976051
[TBL] [Abstract][Full Text] [Related]
14. Optic neuropathy in systemic lupus erythematosus and antiphospholipid syndrome (APS): clinical features, pathogenesis, review of the literature and proposed ophthalmological criteria for APS diagnosis.
Giorgi D; Balacco Gabrieli C
Clin Rheumatol; 1999; 18(2):124-31. PubMed ID: 10357117
[TBL] [Abstract][Full Text] [Related]
15. The interplay between the antiphospholipid syndrome and systemic lupus erythematosus.
Tincani A; Andreoli L; Chighizola C; Meroni PL
Autoimmunity; 2009 May; 42(4):257-9. PubMed ID: 19811269
[TBL] [Abstract][Full Text] [Related]
16. [Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: a report of 3 new cases and a review of the literature].
Blanco Y; Ramos-Casals M; García-Carrasco M; Cervera R; Font J; Ingelmo M
Rev Clin Esp; 1999 Sep; 199(9):586-8. PubMed ID: 10568151
[TBL] [Abstract][Full Text] [Related]
17. Systemic lupus erythematosus and antiphospholipid syndrome with retiform purpura as the initial skin lesion: A case study.
Zhang Y; Yu Y; Gao AT
Lupus; 2023 Apr; 32(4):583-585. PubMed ID: 36888900
[TBL] [Abstract][Full Text] [Related]
18. Bullous systemic lupus erythematosus with antiphospholipid syndrome.
Kacalak-Rzepka A; Zaluga E; Maleszka R; Królicki A; Klimowicz A
J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):490-4. PubMed ID: 15196171
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus.
Campos LM; Kiss MH; D'Amico EA; Silva CA
Lupus; 2003; 12(11):820-6. PubMed ID: 14667097
[TBL] [Abstract][Full Text] [Related]
20. [A case of antiphospholipid syndrome in course of pregnancy and puerperium with lupus-like disease suspicion].
Lorenc A; Seremak-Mrozikiewicz A; Drews K; Ratajczak P; Puszczewicz M
Ginekol Pol; 2011 Apr; 82(4):297-303. PubMed ID: 21735698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
